Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103980377 | 10398037 | 7 | F | 20131229 | 20160720 | 20140821 | 20160727 | EXP | CA-ROCHE-1452780 | ROCHE | 65.76 | YR | F | Y | 0.00000 | 20160727 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103980377 | 10398037 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0051B/S0053A,S00002F | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 103980377 | 10398037 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0051B/S0053A,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103980377 | 10398037 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0051B/S0053A,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103980377 | 10398037 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0051B/S0053A,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103980377 | 10398037 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0051B/S0053A,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103980377 | 10398037 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0051B/S0053A,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103980377 | 10398037 | 7 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | U | 0 | ||||||||||
| 103980377 | 10398037 | 8 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 103980377 | 10398037 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 103980377 | 10398037 | 10 | C | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 103980377 | 10398037 | 11 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103980377 | 10398037 | 1 | Asthma |
| 103980377 | 10398037 | 7 | Product used for unknown indication |
| 103980377 | 10398037 | 8 | Product used for unknown indication |
| 103980377 | 10398037 | 9 | Product used for unknown indication |
| 103980377 | 10398037 | 10 | Product used for unknown indication |
| 103980377 | 10398037 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103980377 | 10398037 | OT |
| 103980377 | 10398037 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103980377 | 10398037 | Asthma | |
| 103980377 | 10398037 | Blood pressure increased | |
| 103980377 | 10398037 | Bronchitis | |
| 103980377 | 10398037 | Cough | |
| 103980377 | 10398037 | Diabetes mellitus | |
| 103980377 | 10398037 | Dizziness | |
| 103980377 | 10398037 | Headache | |
| 103980377 | 10398037 | Influenza | |
| 103980377 | 10398037 | Oropharyngeal pain | |
| 103980377 | 10398037 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103980377 | 10398037 | 1 | 20130319 | 0 | ||
| 103980377 | 10398037 | 2 | 201312 | 201312 | 0 | |
| 103980377 | 10398037 | 4 | 20160429 | 0 | ||
| 103980377 | 10398037 | 5 | 20160527 | 0 | ||
| 103980377 | 10398037 | 6 | 20160623 | 0 |